About Amicrobe
Amicrobe is a private company based in Carlsbad, California. It has reported $22,740,233 raised in three offerings on Form D since February 2011. Its chief executive is Michael Bevilacqua.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 28, 2020 | Apr 25, 2024 | $16,740,243of $24.5M target | 32 | $523K | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Sep 20, 2013 | Apr 25, 2024 | $5,000,003fully sold | 51 | $98,039 | EquityRule 506(b) | Form D ↗ |
| Feb 7, 2011 | Feb 22, 2011 | $999,987of $4.0M target | 5 | $199K | Equity, Series B Preferred Stock, including the shares of Common Stock issuable upon conversion of the Series B Preferred Stock.06 | Form D ↗ |
| Total, three offerings | $22,740,233 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Amicrobe's Form D filed Apr 25, 2024.
AC
Albert Carnesale
Director
MB
Michael Bevilacqua
President and Chief Executive Officer, director
MF
Michael Flesch
Executive officer and director
MB
Martin Burns
Director
DH
Daniel Huang
Executive officer
Earlier filings also listed Scott Hayashi (chief financial officer, last listed Feb 2011) and Joseph Boystak (vice chairman of the board, last listed Feb 2011).